Target intelligence / Profile preview

Lipopolysaccharide layer (LPS layer)

Target
LPS layer
Molecular classification
Other (Bacterial cell envelope component), Not a protein, enzyme, receptor, or classical drug target class
01

Overview

The **lipopolysaccharide layer** is a structural feature unique to the **outer membrane of Gram-negative bacteria**. It consists primarily of **lipopolysaccharides (LPS)**—large amphipathic molecules composed of three main parts: 1. **Lipid A:** The hydrophobic anchor embedded in the bacterial outer membrane; responsible for most toxic effects associated with endotoxemia. 2. **Core oligosaccharide:** A short sugar chain attached directly to lipid A. 3. **O-antigen polysaccharide:** The highly variable, hydrophilic portion extending outward from the bacterium’s surface; determines serotype specificity.[1][2][4][7] The lipopolysaccharide layer serves several critical functions: - It acts as an effective permeability barrier against many antibiotics and harmful agents due to its dense packing and negative charge.[2][4] - It plays a central role in pathogenesis by activating host immune responses—particularly through recognition by innate immune receptors such as Toll-like receptor 4—which can result in fever, inflammation, septic shock, or even death if large amounts are released into circulation during severe infections.[3][6] While individual components like *lipid A* are considered molecular targets for certain drugs such as polymyxins,[general knowledge] the "lipopolysaccharide layer" itself is not typically classified as a therapeutic target like receptors or enzymes. **Note on correctness:** The term “Lipopolysaccharide layer” refers broadly to a structural feature rather than a discrete molecular entity such as an enzyme or receptor. Therefore, it is *not considered* a canonical drug target per se—it does not have gene/protein identifiers nor typical ligand-binding properties associated with pharmacological targets.[1–7]

Other names
Lipopolysaccharide (LPS)EndotoxinLPS outer membraneGram-negative bacterial outer membrane LPSBacterial endotoxin layer
02

Mechanism of action

Disruption of bacterial outer membrane integrity by binding to lipid A component of LPS, leading to increased permeability and cell death [general knowledge].

03

Biological functions

Structural barrier for Gram-negative bacteria[2][3][6]Immune system activation (potent activator of innate immunity)[3][6]Pathogenesis and virulence factor[3][6]Selective permeability barrier[2][3][6]Protection against host defenses and environmental stress[3]
04

Disease associations

Infection (especially sepsis/endotoxic shock)[3][6]Inflammation (triggering cytokine release and systemic inflammatory response)[7]
05

Safety considerations

Potent induction of endotoxic shock if released into circulation during infection or antibiotic treatment[7].Strong immune activation can lead to systemic inflammation and organ failure.
06

Interacting drugs

Polymyxins (e.g., colistin/polymyxin B)
07

Biomarkers

No established biomarkers specific for patient selection based on the presence of an "LPS layer," but detection of circulating endotoxin/LPS is used as a marker for Gram-negative infection/sepsis.

Beyond the preview

Go deeper on Lipopolysaccharide layer (LPS layer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide layer (LPS layer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call